8062. Response by Lüker et al to Letter Regarding Article, "Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial".
作者: Jakob Lüker.;Kathrin Kuhr.;Arian Sultan.;Georg Nölker.;Hazem Omran.;Stephan Willems.;René Andrié.;Jan W Schrickel.;Stefan Winter.;Dirk Vollmann.;Roland R Tilz.;Alexander Jobs.;Christian-H Heeger.;Andreas Metzner.;Sven Meyer.;Karl Mischke.;Andreas Napp.;Andreas Fahrig.;Susanne Steinhauser.;Johannes Brachmann.;Stephan Baldus.;Rajiv Mahajan.;Prashanthan Sanders.;Daniel Steven.
来源: Circulation. 2020年141卷8期e95-e96页 8063. Privacy Gaps for Digital Cardiology Data: Big Problems With Big Data.
作者: Jessica R Golbus.;W Nicholson Price.;Brahmajee K Nallamothu.
来源: Circulation. 2020年141卷8期613-615页
Mr. M is a 55 year-old man who suffers an acute myocardial infarction (MI) and undergoes coronary stenting. Following hospitalization, he completes cardiac rehabilitation. Thereafter, he is approached about joining a digital smartwatch study to help monitor his health behaviors. He enrolls with enthusiasm, and, feeling empowered, creates a profile on PatientsLikeMe to share lessons from his medical journey. There he reads about an over-the-counter vitamin and downloads a coupon for his local supermarket. Determined to remain accountable for his health, he starts exercising with a fitness trainer and provides her with heart rate data from his smartwatch. He also downloads a mobile nutrition application she recommends.
8066. Letter by Sugimoto and Taniguchi Regarding Article, "Internal Versus External Electrical Cardioversion of Atrial Arrhythmia in Patients With Implantable Cardioverter-Defibrillator: A Randomized Clinical Trial".8068. Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure.
作者: Stephan Rosenkranz.;Luke S Howard.;Mardi Gomberg-Maitland.;Marius M Hoeper.
来源: Circulation. 2020年141卷8期678-693页
Pulmonary hypertension (PH) is a feature of a variety of diseases and continues to harbor high morbidity and mortality. The main consequence of PH is right-sided heart failure which causes a complex clinical syndrome affecting multiple organ systems including left heart, brain, kidneys, liver, gastrointestinal tract, skeletal muscle, as well as the endocrine, immune, and autonomic systems. Interorgan crosstalk and interdependent mechanisms include hemodynamic consequences such as reduced organ perfusion and congestion as well as maladaptive neurohormonal activation, oxidative stress, hormonal imbalance, and abnormal immune cell signaling. These mechanisms, which may occur in acute, chronic, or acute-on-chronic settings, are common and precipitate adverse functional and structural changes in multiple organs which contribute to increased morbidity and mortality. While the systemic character of PH and right-sided heart failure is often neglected or underestimated, such consequences place additional burden on patients and may represent treatable traits in addition to targeted therapy of PH and underlying causes. Here, we highlight the current state-of-the-art understanding of the systemic consequences of PH and right-sided heart failure on multiple organ systems, focusing on self-perpetuating pathophysiological mechanisms, aspects of increased susceptibility of organ damage, and their reciprocal impact on the course of the disease.
8069. Do Fractional Flow Reserve and Instantaneous Wave-Free Ratio Correlate With Exercise Coronary Physiology?
作者: Matthew Ryan.;Bhavik Modi.;Haseeb Rahman.;Rupert Williams.;Satpal Arri.;Kaleab Asrress.;Matthew Lumley.;Howard Ellis.;Simon Redwood.;Divaka Perera.
来源: Circ Cardiovasc Interv. 2020年13卷3期e008415页 8070. Comparison of Transfemoral Versus Transradial Secondary Access in Transcatheter Aortic Valve Replacement.
作者: Lucía Junquera.;Marina Urena.;Azeem Latib.;Antonio Muñoz-Garcia.;Luis Nombela-Franco.;Benjamin Faurie.;Gabriela Veiga-Fernandez.;Alberto Alperi.;Vicenç Serra.;Ander Regueiro.;Quentin Fischer.;Dominique Himbert.;Antonio Mangieri.;Antonio Colombo.;Erika Muñoz-García.;Rafael Vera-Urquiza.;Pilar Jiménez-Quevedo.;Jose Maria de la Torre.;Isaac Pascual.;Bruno Garcia Del Blanco.;Manel Sabaté.;Siamak Mohammadi.;Afonso B Freitas-Ferraz.;Leonardo Guimarães.;Thomas Couture.;Melanie Côté.;Josep Rodés-Cabau.
来源: Circ Cardiovasc Interv. 2020年13卷3期e008609页
Transfemoral approach has been commonly used as secondary access in transcatheter aortic valve replacement (TAVR). Scarce data exist on the use and potential clinical benefits of the transradial approach as secondary access during TAVR procedures. The objective of the study is to determine the occurrence of vascular complications (VC) and clinical outcomes according to secondary access (transfemoral versus transradial) in patients undergoing TAVR.
8071. Predictors for Clinical Outcome of Untreated Stent Edge Dissections as Detected by Optical Coherence Tomography.
作者: Laurens J C van Zandvoort.;Mariusz Tomaniak.;Maria Natalia Tovar Forero.;Kaneshka Masdjedi.;Lisanne Visseren.;Karen Witberg.;Jurgen Ligthart.;Isabella Kardys.;Miguel E Lemmert.;Roberto Diletti.;Jeroen Wilschut.;Peter de Jaegere.;Felix Zijlstra.;Nicolas M Van Mieghem.;Joost Daemen.
来源: Circ Cardiovasc Interv. 2020年13卷3期e008685页 8072. Comprehensive Diagnostic Evaluation of Cardiovascular Physiology in Patients With Pulmonary Vascular Disease: Insights From the PVDOMICS Program.
作者: W H Wilson Tang.;Jennifer D Wilcox.;Miriam S Jacob.;Erika B Rosenzweig.;Barry A Borlaug.;Robert P Frantz.;Paul M Hassoun.;Anna R Hemnes.;Nicholas S Hill.;Evelyn M Horn.;Harsimran S Singh.;David M Systrom.;Ryan J Tedford.;Rebecca R Vanderpool.;Aaron B Waxman.;Lei Xiao.;Jane A Leopold.;Franz P Rischard.
来源: Circ Heart Fail. 2020年13卷3期e006363页
Invasive hemodynamic evaluation through right heart catheterization plays an essential role in the diagnosis, categorization, and risk stratification of patients with pulmonary hypertension.
8073. Telecommunicator Cardiopulmonary Resuscitation: A Policy Statement From the American Heart Association.
作者: Michael Christopher Kurz.;Bentley J Bobrow.;Julie Buckingham.;Jose G Cabanas.;Mickey Eisenberg.;Peter Fromm.;Micah J Panczyk.;Tom Rea.;Kevin Seaman.;Christian Vaillancourt.; .
来源: Circulation. 2020年141卷12期e686-e700页
Every year in the United States, >350 000 people have sudden cardiac arrest outside of a hospital environment. Sudden cardiac arrest is the unexpected loss of heart function, breathing, and consciousness and is commonly the result of an electric disturbance in the heart. Unfortunately, only ≈1 in 10 victims survives this dramatic event. Early access to 9-1-1 and early cardiopulmonary resuscitation (CPR) are the first 2 links in the chain of survival for out-of-hospital cardiac arrest. Although 9-1-1 is frequently accessed, in the majority of cases, individuals with out-of-hospital cardiac arrest do not receive lay rescuer CPR and wait for the arrival of professional emergency rescuers. Telecommunicators are the true first responders and a critical link in the cardiac arrest chain of survival. In partnership with the 9-1-1 caller, telecommunicators have the first opportunity to identify a patient in cardiac arrest and provide initial care by delivering CPR instructions while quickly dispatching emergency medical services. The telecommunicator and the caller form a unique team in which the expertise of the telecommunicator is provided just in time to a willing caller, transforming the caller into a lay rescuer delivering CPR. The telecommunicator CPR (T-CPR) process, also previously described as dispatch CPR, dispatch-assisted CPR, or telephone CPR, represents an important opportunity to improve survival from sudden cardiac arrest. Conversely, failure to provide T-CPR in this manner results in preventable harm. This statement describes the public health impact of out-of-hospital cardiac arrest, provides guidance and resources to construct and maintain a T-CPR program, outlines the minimal acceptable standards for timely and high-quality delivery of T-CPR instructions, and identifies strategies to overcome common implementation barriers to T-CPR.
8077. Variant Frequency and Clinical Phenotype Call Into Question the Nature of Minor, Nonsyndromic Long-QT Syndrome-Susceptibility Gene-Disease Associations.
作者: John R Giudicessi.;Ram K Rohatgi.;David J Tester.;Michael J Ackerman.
来源: Circulation. 2020年141卷6期495-497页 8078. Response by Kuwabara et al to Letter Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized Controlled Trial".
作者: Masanari Kuwabara.;Jun Sasaki.;Tetsunori Saikawa.;Yasuyoshi Ouchi.
来源: Circulation. 2020年141卷6期e67-e68页 8079. Letter by Weingärtner et al Regarding Article, "Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75): A Randomized, Controlled Trial". |